SHANGHAI RENDU BIOTECHNOLOGY financial statements, including revenue, expenses, profit, and loss

The total revenue of 688193 for the last quarter is 43.72 M CNY, and it's 5.05% higher compared to the previous quarter. The net income of Q3 24 is 340.38 k CNY.